Characteristics of Cobalt-Related Cardiomyopathy in Metal Hip Implant Patients: An Evaluation of 15 Published Reports

[1]  D. Paustenbach,et al.  Characterization of wear debris from metal-on-metal hip implants during normal wear versus edge-loading conditions. , 2018, Journal of biomedical materials research. Part B, Applied biomaterials.

[2]  P. Kellman,et al.  Assessing for Cardiotoxicity from Metal-on-Metal Hip Implants with Advanced Multimodality Imaging Techniques , 2017, The Journal of bone and joint surgery. American volume.

[3]  M. Packer.  Cobalt Cardiomyopathy: A Critical Reappraisal in Light of a Recent Resurgence , 2016, Circulation. Heart failure.

[4]  J. Yanta,et al.  Fatal cobalt toxicity after total hip arthroplasty revision for fractured ceramic components , 2016, Clinical toxicology.

[5]  N. Vasukutty,et al.  Systemic Effects of Cobalt Toxicity after Revision Hip Replacement can Manifest in Intermediate to Long Term Follow-Up , 2016, Hip international : the journal of clinical and experimental research on hip pathology and therapy.

[6]  Brian Mosier,et al.  Progressive Cardiomyopathy in a Patient With Elevated Cobalt Ion Levels and Bilateral Metal-on-Metal Hip Arthroplasties. , 2016, American journal of orthopedics.

[7]  Christopher M. O'Connor,et al.  Pathophysiology and clinical evaluation of acute heart failure , 2016, Nature Reviews Cardiology.

[8]  Christopher L. Camp,et al.  Cardiac cobaltism: a rare complication after bilateral metal-on-metal total hip arthroplasty , 2015, Arthroplasty today.

[9]  M. Doyle,et al.  Novel Use of Cardiac Magnetic Resonance Imaging for the Diagnosis of Cobalt Cardiomyopathy. , 2015, JACC. Cardiovascular imaging.

[10]  Akbar H. Khan,et al.  Unusual case of congestive heart failure: cardiac magnetic resonance imaging and histopathologic findings in cobalt cardiomyopathy. , 2015, Circulation. Cardiovascular imaging.

[11]  Brooke E. Tvermoes,et al.  Review of cobalt toxicokinetics following oral dosing: Implications for health risk assessments and metal-on-metal hip implant patients , 2015, Critical reviews in toxicology.

[12]  T. Guggi,et al.  Wear and Tear Vision , 2015, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

[13]  Brent D Kerger,et al.  Refined biokinetic model for humans exposed to cobalt dietary supplements and other sources of systemic cobalt exposure. , 2014, Chemico-biological interactions.

[14]  D. Lonati,et al.  Chelation in suspected prosthetic hip-associated cobalt toxicity. , 2014, The Canadian journal of cardiology.

[15]  C. Engh,et al.  Metal ion levels after metal-on-metal total hip arthroplasty: a five-year, prospective randomized trial. , 2014, The Journal of bone and joint surgery. American volume.

[16]  S. Pankuweit,et al.  Cobalt intoxication diagnosed with the help of Dr House , 2014, The Lancet.

[17]  L. Allen,et al.  Clinical problem-solving. Missing elements of the history. , 2014, The New England journal of medicine.

[18]  D. Paustenbach,et al.  Interpreting cobalt blood concentrations in hip implant patients , 2014, Clinical toxicology.

[19]  A. Seidler,et al.  Metal Ion Concentrations in Body Fluids after Implantation of Hip Replacements with Metal-on-Metal Bearing – Systematic Review of Clinical and Epidemiological Studies , 2013, PloS one.

[20]  M. Klapholz,et al.  Uremic cardiomyopathy: an underdiagnosed disease. , 2013, Congestive heart failure.

[21]  Christiaan P. van Lingen,et al.  Clinical Manifestations in Ten Patients with Asymptomatic Metal-on-Metal Hip Arthroplasty with Very High Cobalt Levels , 2013, Hip international : the journal of clinical and experimental research on hip pathology and therapy.

[22]  M. Paley,et al.  Metal-on-Metal Hip Prostheses and Systemic Health: A Cross-Sectional Association Study 8 Years after Implantation , 2013, PloS one.

[23]  A. Garg,et al.  No increase in adverse events during aliskiren use among ontario patients receiving angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers. , 2013, The Canadian journal of cardiology.

[24]  A. Cheung,et al.  Hip pain and heart failure: the missing link. , 2013, The Canadian journal of cardiology.

[25]  R. P. Sidaginamale,et al.  Blood metal ion testing is an effective screening tool to identify poorly performing metal-on-metal bearing surfaces , 2013, Bone & joint research.

[26]  H. Gill,et al.  The 2012 Otto Aufranc Award: The Interpretation of Metal Ion Levels in Unilateral and Bilateral Hip Resurfacing , 2013, Clinical orthopaedics and related research.

[27]  C. Overgaard,et al.  Fatal cardiomyopathy after revision total hip replacement for fracture of a ceramic liner. , 2013, The bone & joint journal.

[28]  Warren Apel,et al.  Cobalt–chromium toxic retinopathy case study , 2013, Documenta Ophthalmologica.

[29]  D. Paustenbach,et al.  Dose-Response Relationships For Blood Cobalt Concentrations and Health Effects: A Review of the Literature and Application of a Biokinetic Model , 2012, Journal of toxicology and environmental health. Part B, Critical reviews.

[30]  Colin Machado,et al.  Arthroprosthetic cobaltism and cardiomyopathy. , 2012, Heart, lung & circulation.

[31]  T. Vittorio,et al.  A perspective on obesity cardiomyopathy. , 2012, Obesity research & clinical practice.

[32]  D. Pelclova,et al.  Severe cobalt intoxication following hip replacement revision: Clinical features and outcome , 2012, Clinical toxicology.

[33]  Snehal R. Patel,et al.  Combined heart and liver transplantation in an adult with familial heterozygous hypercholesterolemia and severe ischemic cardiomyopathy. , 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[34]  Barry J Maron,et al.  2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines , 2011, Circulation.

[35]  Barry J Maron,et al.  2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines , 2011, Circulation.

[36]  Barry J Maron,et al.  2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2011, The Journal of thoracic and cardiovascular surgery.

[37]  M. Oldenburg,et al.  Severe cobalt intoxication due to prosthesis wear in repeated total hip arthroplasty. , 2009, The Journal of arthroplasty.

[38]  T. Elton,et al.  Cardiomyopathy: an overview. , 2009, American family physician.

[39]  John Fisher,et al.  High Cup Angle and Microseparation Increase the Wear of Hip Surface Replacements , 2009, Clinical orthopaedics and related research.

[40]  C. Engh,et al.  2008 John Charnley Award: Metal Ion Levels After Metal-on-Metal Total Hip Arthroplasty: A Randomized Trial , 2009, Clinical orthopaedics and related research.

[41]  P. Campbell,et al.  Correlation between inclination of the acetabular component and metal ion levels in metal-on-metal hip resurfacing replacement. , 2008, The Journal of bone and joint surgery. British volume.

[42]  L. Walter,et al.  Distribution of chromium and cobalt ions in various blood fractions after resurfacing hip arthroplasty. , 2008, The Journal of arthroplasty.

[43]  Michael M Morlock,et al.  Modes of implant failure after hip resurfacing: morphological and wear analysis of 267 retrieval specimens. , 2008, The Journal of bone and joint surgery. American volume.

[44]  E. Abel,et al.  Diabetic cardiomyopathy revisited. , 2007, Circulation.

[45]  R. Virmani,et al.  An analytical comparison of cobalt cardiomyopathy and idiopathic dilated cardiomyopathy , 1996, Biological Trace Element Research.

[46]  J. Foster,et al.  Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging. , 2006, Kidney international.

[47]  Barry J Maron,et al.  Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interd , 2006, Circulation.

[48]  A. Cobb,et al.  The clinical significance of metal ion release from cobalt-chromium metal-on-metal hip joint arthroplasty , 2006, Proceedings of the Institution of Mechanical Engineers. Part H, Journal of engineering in medicine.

[49]  Alessandro Alimonti,et al.  Assessment of reference values for selected elements in a healthy urban population. , 2005, Annali dell'Istituto superiore di sanita.

[50]  S. MacDonald.  Can a safe level for metal ions in patients with metal-on-metal total hip arthroplasties be determined? , 2004, The Journal of arthroplasty.

[51]  D. Zukor,et al.  Size, shape, and composition of wear particles from metal-metal hip simulator testing: effects of alloy and number of loading cycles. , 2003, Journal of biomedical materials research. Part A.

[52]  D. Bell,et al.  Diabetic cardiomyopathy. , 2003, Diabetes care.

[53]  M. A. Fraley,et al.  Management of obesity cardiomyopathy , 2005, The American journal of the medical sciences.

[54]  A. Jardine,et al.  Cardiovascular complications of renal disease , 2001, Heart.

[55]  J. Galante,et al.  Local and distant products from modularity. , 1995, Clinical orthopaedics and related research.

[56]  G. Mosconi,et al.  Cobalt myocardiopathy. A critical review of literature. , 1994, The Science of the total environment.

[57]  J. Jarvis,et al.  Cobalt cardiomyopathy. A report of two cases from mineral assay laboratories and a review of the literature. , 1992, Journal of occupational medicine. : official publication of the Industrial Medical Association.

[58]  J. Alexander.  The cardiomyopathy of obesity. , 1985, Progress in cardiovascular diseases.

[59]  A. Kennedy,et al.  FATAL MYOCARDIAL DISEASE ASSOCIATED WITH INDUSTRIAL EXPOSURE TO COBALT , 1981, The Lancet.

[60]  E. Sonnenblick,et al.  Clinical and morphological features of human hypertensive-diabetic cardiomyopathy. , 1980, American heart journal.

[61]  M. Platts,et al.  Cobalt cardiomyopathy in a patient on maintenance haemodialysis. , 1978, British medical journal.

[62]  S. Ahmed,et al.  Evidence for cardiomyopathy in familial diabetes mellitus. , 1977, The Journal of clinical investigation.

[63]  E. Herman,et al.  Toxic cardiomyopathies. , 1976, Annals of clinical and laboratory science.

[64]  C. S. Alexander.  Cobalt-beer cardiomyopathy. A clinical and pathologic study of twenty-eight cases. , 1972, The American journal of medicine.

[65]  M. Barborík,et al.  Cardiomyopathy accompaning industrial cobalt exposure. , 1972, British heart journal.

[66]  P. Daniel,et al.  Quebec beer-drinkers' cardiomyopathy: etiological considerations. , 1967, Canadian Medical Association journal.

[67]  J. Sullivan,et al.  Myocardosis and cardiac failure in men. , 1966, JAMA.

[68]  G K McKee,et al.  Replacement of arthritic hips by the McKee-Farrar prosthesis. , 1966, The Journal of bone and joint surgery. British volume.

[69]  J N Wilson,et al.  Epiphyseal transplantation. A clinical study. , 1966, The Journal of bone and joint surgery. American volume.

[70]  J. C. Brennan,et al.  The Cardiac Pathology of Chronic Exogenous Obesity , 1965, Circulation.

[71]  M. Smith-Petersen.  Evolution of mould arthroplasty of the hip joint. , 1948, The Journal of bone and joint surgery. British volume.